The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper,

Slides:



Advertisements
Similar presentations
Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results.
Advertisements

Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: A controlled trial  Arja T. Erkkilä, PhD, Ursula.
Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements 
Hypertension-Lipid Connection: Introduction
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia  Pablo Lázaro, MD, PhD, MBA, Leopoldo Pérez.
Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,
Individual omega-9 monounsaturated fatty acids and mortality—The Ludwigshafen Risk and Cardiovascular Health Study  Graciela E. Delgado, MSc, Bernhard.
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.
Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results.
An assessment by the Statin Cognitive Safety Task Force: 2014 update
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial.
An assessment by the Statin Muscle Safety Task Force: 2014 update
An assessment by the Statin Liver Safety Task Force: 2014 update
Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled.
Dose-Response Relationship Between Severe Hypercholesterolemia and Body Mass Index in Healthy Young Adults  Tomohide Yamada, MD, PhD, Shintaro Yanagimoto,
Female exposure to phenols and phthalates and time to pregnancy: the Maternal-Infant Research on Environmental Chemicals (MIREC) Study  Maria P. Vélez,
Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients  Evan Stein, MD, Harold Bays, MD, Michael Koren,
Dose-Response Relationship Between Severe Hypercholesterolemia and Body Mass Index in Healthy Young Adults  Tomohide Yamada, MD, PhD, Shintaro Yanagimoto,
Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia  Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,
Accuracy of a Diagnostic Algorithm to Diagnose Breakthrough Cancer Pain as Compared With Clinical Assessment  Katherine Webber, MBBS, MSc, PhD, Andrew.
Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with.
Reduction of C-reactive protein levels through use of a multivitamin
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:
Normal Weight-Central Obesity Is Associated with the Highest Mortality Risk in Older Adults with Coronary Artery Disease*†  Saurabh Sharma, MD, John A.
Predictors of first-year statin medication discontinuation: A cohort study  Heli Halava, MD, Risto Huupponen, MD, PhD, Jaana Pentti, BSc, Mika Kivimäki,
Trevor Williams, MD, MPH, Brian C
Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: A controlled trial  Arja T. Erkkilä, PhD, Ursula.
The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper,
Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study) 
Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles  Jan.
A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia  Gisle Langslet, MD, Andrei Breazna, PhD, Euridiki.
Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance 
J. W. Balder, MD, PhD, P. J. Lansberg, MD, PhD, M. H. Hof, MSc, A
Temporal Trends in Lipid Screening for Familial Hypercholesterolemia in Youth  Catherine J. McNeal, MD, PhD, Justin Zachariah, MD, MPH, Laurel Copeland,
Meredith Kilgore, PhD, Paul Muntner, PhD, J
Emma J. Aarnio, MSc (Pharm), Janne A
Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?  Joana Rita Chora, MSc, Ana Catarina Alves, PhD, Ana.
Charles J. Glueck, MD, Alan Brown, MD, Anne C. Goldberg, MD, James M
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary  Terry A. Jacobson, MD, Matthew.
Temporal Trends in Lipid Screening for Familial Hypercholesterolemia in Youth  Catherine J. McNeal, MD, PhD, Justin Zachariah, MD, MPH, Laurel Copeland,
Paul D. Thompson, MD, John Rubino, MD, Matthew J. Janik, MD, Diane E
Short Total Sleep Time and Elevated Central Apnea Index are Significant Predictors of Coronary Artery Disease*  Tina Constantin, MD, Jeremy R. Anthony,
Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1  Omar Abdel-Razek, MD, Singh N.
Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National.
An assessment by the Statin Intolerance Panel: 2014 update
Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles  Jan.
Higher triglyceride level predicts hyperuricemia: A prospective study of 6-year follow-up  Yuan Zhang, Fengjiang Wei, PhD, Chen Chen, MD, Chunyou Cai,
Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results.
Trevor Williams, MD, MPH, Brian C
Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia  G. Kees Hovingh, MD,
Optimal high-density lipoprotein cholesterol cutoff for predicting cardiovascular disease: Comparison of the Korean and US National Health and Nutrition.
Are the Institute of Medicine Recommendations for Gestational Weight Gain Appropriate for Adolescents?  Susan Groth, PHD, RNC, NP  Journal of Obstetric,
Sokunthea Peou, PharmD, Brittany Milliard-Hasting, MD, Sachin A
Familial hypercholesterolemia in a European Mediterranean population—Prevalence and clinical data from 2.5 million primary care patients  Alberto Zamora,
Patterns of statin use and cholesterol goal attainment in a high-risk cardiovascular population: A retrospective study of primary care electronic medical.
Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials  Allan D. Sniderman, MD, James A. Sloand,
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT.
Table of contents The Journal for Nurse Practitioners
Christopher S. Penet, Brian H. Annex, MD, Kelly T. Gregory, R
Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia  Martine Paquette, MSc, Sophie.
Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review  Ilse K. Luirink, MD, Jim.
Higher long-term adherence to statins in rural patients at high atherosclerotic risk  Matthew R. Peverelle, MD, BBiomed, Arul Baradi, MBChB, Sarang Paleri,
Can Low-Radiation Coronary Computed Tomography Angiography Improve Upon Clinical Risk Assessment in Patients with Familial Hypercholesterolemia?*  Anna.
A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine  Donald G. Lamprecht, PharmD, Anne M.
Prediction of Cardiovascular Disease Events by Lipoprotein(a) According to LDL-C in Older High Risk Adults  Nathan D. Wong, PhD, Shravanthi R. Gandra,
What Is Chronic Cough? Terminology
LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design  Dirk J. Blom, MD, PhD, Zahi A. Fayad,
Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia  Anna.
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary  Terry A. Jacobson, MD, Matthew.
News & Notes Journal of Allergy and Clinical Immunology
Presentation transcript:

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper, MSc, Peter Dale, MBBS, FRCPCH, Uma Ramaswami, MD  Journal of Clinical Lipidology  Volume 12, Issue 1, Pages 25-32 (January 2018) DOI: 10.1016/j.jacl.2017.11.005 Copyright © 2017 National Lipid Association Terms and Conditions

Figure 1 Distribution of (A) BMI and (B) age and gender BMI percentile in 243 FH children. (A) 17/243 = 7% had a BMI between 25 and 30 kg/m2 (light stipple bars) and 5/243 = 2.1% had a BMI > 30 kg/m2 (dark stipple bars). (B) 41/243 = 16.9% had an age- and gender-adjusted BMI percentile >85th percentile (light stipple bar) and 27/243 = 11.1% had an age- and gender-adjusted BMI percentile >95th percentile (dark stipple bar). BMI, body mass index; FH, familial hypercholesterolemia. Journal of Clinical Lipidology 2018 12, 25-32DOI: (10.1016/j.jacl.2017.11.005) Copyright © 2017 National Lipid Association Terms and Conditions